Literature DB >> 2998114

Increased virulence of an infectious bursal disease live virus vaccine after passage in chicks.

J C Muskett, N E Reed, D H Thornton.   

Abstract

A live infectious bursal disease virus vaccine increased in virulence when passaged six times in susceptible birds, as judged by damage to the bursa of Fabricius. It is suggested that the increase in virulence of this vaccine was due to the selection of a virulent subpopulation which had been present in the vaccine since its original isolation from the field and which had not been eliminated during its attenuation by passage in cell culture. The vaccine was then plaque purified and a virus strain was selected which protected against challenge, did not damage the bursa and appeared not to passage in birds.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998114     DOI: 10.1016/s0264-410x(85)90161-6

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Pathogenicity and immunosuppressive properties of infectious bursal disease virus field isolates and commercial vaccines in India.

Authors:  A Thangavelu; G D Raj; S Elankumaran; B M Manohar; A Koteeswaran; A T Venugopalan
Journal:  Trop Anim Health Prod       Date:  1998-06       Impact factor: 1.559

Review 2.  Farming of Plant-Based Veterinary Vaccines and Their Applications for Disease Prevention in Animals.

Authors:  Pit Sze Liew; Mohd Hair-Bejo
Journal:  Adv Virol       Date:  2015-08-13

3.  Recombinant Marek's disease virus type 1 provides full protection against very virulent Marek's and infectious bursal disease viruses in chickens.

Authors:  Kai Li; Yongzhen Liu; Changjun Liu; Li Gao; Yanping Zhang; Hongyu Cui; Yulong Gao; Xiaole Qi; Li Zhong; Xiaomei Wang
Journal:  Sci Rep       Date:  2016-12-16       Impact factor: 4.379

4.  A review of vaccine development and research for industry animals in Korea.

Authors:  Nak-Hyung Lee; Jung-Ah Lee; Seung-Yong Park; Chang-Seon Song; In-Soo Choi; Joong-Bok Lee
Journal:  Clin Exp Vaccine Res       Date:  2012-07-31

5.  Safety, immunogenicity and duration of immunity elicited by an inactivated bovine ephemeral fever vaccine.

Authors:  Orly Aziz-Boaron; Keren Leibovitz; Boris Gelman; Maor Kedmi; Eyal Klement
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.